MedPPP Completed Pre-A Round of Financing of 10 Million Yuan

According to Lieyunwang.com, MedPPP has completed a 10-million-yuan Pre-A round of financing in October this year, invested by individuals. Ren Siyuan, the founder of MedPPP, said this round of financing would mainly be used for the research and development of its precision medicine platform, team expansion, and market promotion. MedPPP closed on its angel round of financing in July 2017.

Founded in May 2016, MedPPP is committed to using big data and artificial intelligence for precision medicine, providing medical natural language understanding, big data analysis and biomedical model construction for hospitals.

MedPPP has cooperated with the Chinese Academy of Sciences and a number of first-class hospitals to develop the interpretation model of inspection reports, which can support intelligent analysis. At the same time, medical professionals can use data including biochemical and immunological data, and genetic test results to predict disease classification, and guide medication and prognosis. In addition, MedPPP can discover new test indicators based on historical data, which will be used in test chips or kits to assist clinical decision-making.

“The development of digital health in China is relatively mature and has broken the geographical and time limitations. However, the industry is still in its infancy and will bring more subversive changes to the whole medical industry. We need to break the traditional ideas and habits, “Ren Siyuan said.

Ren Siyuan used to study medical informatics and artificial intelligence in the United States and has been engaged in the development of commercial-level big data platforms for many years. He hopes that in the future, MedPPP can provide more clinical services, including intelligent diagnosis, classification of subtypes of diseases, personalized selection of drugs, prognosis and so on.